Realigned transsulfuration drives BRAF-V600E-targeted therapy resistance in melanoma
Klaudia Borbényi-Galambos(University of Debrecen), Péter Nagy(National Institute of Oncology), Mihály Cserepes(National Institute of Oncology), Ágnes Czikora(National Institute of Oncology), Réka Szatmári(University of Debrecen), Tamás Ditrói(National Institute of Oncology), Eszter Petra Jurányi(Semmelweis University), Edward E. Schmidt(Montana State University), Erika Tóth(National Institute of Oncology), József Tóvári(National Institute of Oncology), Dorottya Garai(University of Debrecen), Noémi Szántó(National Institute of Oncology), Katalin Erdélyi(The University of Texas Medical Branch at Galveston), Gabriella Liszkay(National Institute of Oncology)
Cited by 19
Related Papers
Control of protein function through oxidation and reduction of persulfidated states
|Science Advances|2020|205
Interactions of reactive sulfur species with metalloproteins
|Redox Biology|2023|62
Human ultrarare genetic disorders of sulfur metabolism demonstrate redundancies in H2S homeostasis
|Redox Biology|2022|35
Improved In Vivo Anti-Tumor and Anti-Metastatic Effect of GnRH-III-Daunorubicin Analogs on Colorectal and Breast Carcinoma Bearing Mice
|International Journal of Molecular Sciences|2019|29